NCT06099132View on ClinicalTrials.gov

Antagonist Activation Measurement at the Ankle Using High-density and Bipolar Surface EMG in Chronic Hemiparesis

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
StrokeMuscle HypertoniaSpasticity, Muscle
Interventions
DIAGNOSTIC_TEST

Electromyographic measurements

HD and bipolar EMG were assessed from gastrocnemius medialis (GM), soleus (SO) and tibialis anterior (TA) at seated position, ankle at 0°, during isometric submaximal effort and maximal effort, knee flexed (90°) and knee extended (0°)

All Listed Sponsors
lead

Henri Mondor University Hospital

OTHER

NCT06099132 - Antagonist Activation Measurement at the Ankle Using High-density and Bipolar Surface EMG in Chronic Hemiparesis | Biotech Hunter | Biotech Hunter